KANSL1L

gene
On this page

Also known as FLJ23861FLJ32349MSL1v2KIAA1267L

Summary

KANSL1L (KAT8 regulatory NSL complex subunit 1 like, HGNC:26310) is a protein-coding gene on chromosome 2q34, encoding KAT8 regulatory NSL complex subunit 1-like protein (A0AUZ9).

Predicted to enable histone acetyltransferase binding activity. Predicted to be located in intracellular membrane-bounded organelle. Predicted to be part of NSL complex.

Source: NCBI Gene 151050 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 156 total — 1 pathogenic
  • MANE Select transcript: NM_152519

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26310
Approved symbolKANSL1L
NameKAT8 regulatory NSL complex subunit 1 like
Location2q34
Locus typegene with protein product
StatusApproved
AliasesFLJ23861, FLJ32349, MSL1v2, KIAA1267L
Ensembl geneENSG00000144445
Ensembl biotypeprotein_coding
OMIM613833
Entrez151050

Gene structure

Transcript identifiers

Ensembl transcripts: 17 — 13 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron, 1 nonsense_mediated_decay

ENST00000281772, ENST00000415553, ENST00000418791, ENST00000428655, ENST00000429908, ENST00000438563, ENST00000452086, ENST00000453904, ENST00000457374, ENST00000460256, ENST00000634716, ENST00000867424, ENST00000867425, ENST00000867426, ENST00000867427, ENST00000967984, ENST00000967985

RefSeq mRNA: 2 — MANE Select: NM_152519 NM_001307976, NM_152519

CCDS: CCDS33370, CCDS77519

Canonical transcript exons

ENST00000281772 — 15 exons

ExonStartEnd
ENSE00000965169210104104210104301
ENSE00001002835210029803210029918
ENSE00001002840210027296210027350
ENSE00001002842210028845210028969
ENSE00001002843210031421210031546
ENSE00001123725210040420210040527
ENSE00001173078210075552210075756
ENSE00001336989210043939210044104
ENSE00001362522210129031210129172
ENSE00001504502210024033210024201
ENSE00001504503210025104210025216
ENSE00001618187210153495210154611
ENSE00001643572210021421210023179
ENSE00001804956210171149210171409
ENSE00003503204210098086210098207

Expression profiles

Bgee: expression breadth ubiquitous, 267 present calls, max score 95.65.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.7382 / max 110.0044, expressed in 1646 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
334574.88521528
334581.1634637
334560.6896314

Top tissues by expression

283 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370195.65gold quality
nerveUBERON:000102192.61gold quality
tibial nerveUBERON:000132392.61gold quality
popliteal arteryUBERON:000225092.30gold quality
tibial arteryUBERON:000761092.29gold quality
adrenal tissueUBERON:001830391.94gold quality
sural nerveUBERON:001548891.71gold quality
left ovaryUBERON:000211991.12gold quality
aortaUBERON:000094790.85gold quality
right ovaryUBERON:000211890.46gold quality
right lungUBERON:000216790.27gold quality
descending thoracic aortaUBERON:000234590.17gold quality
right uterine tubeUBERON:000130289.70gold quality
endocervixUBERON:000045889.68gold quality
metanephros cortexUBERON:001053389.33gold quality
thoracic aortaUBERON:000151589.26gold quality
ascending aortaUBERON:000149689.22gold quality
body of pancreasUBERON:000115089.19gold quality
ovaryUBERON:000099289.18gold quality
left coronary arteryUBERON:000162689.13gold quality
left lobe of thyroid glandUBERON:000112088.97gold quality
bronchial epithelial cellCL:000232888.90gold quality
right coronary arteryUBERON:000162588.90gold quality
gall bladderUBERON:000211088.80gold quality
ventricular zoneUBERON:000305388.62gold quality
right lobe of thyroid glandUBERON:000111988.55gold quality
thyroid glandUBERON:000204688.48gold quality
body of uterusUBERON:000985388.24gold quality
mucosa of stomachUBERON:000119988.03gold quality
ectocervixUBERON:001224987.74gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.32
E-MTAB-6386no35.50

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

140 targeting KANSL1L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-3924100.0072.092394
HSA-MIR-8485100.0077.574731
HSA-MIR-5692B100.0071.322622
HSA-MIR-5692C100.0071.322622
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-511-3P99.9968.851467
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-4789-5P99.9870.762721
HSA-MIR-477599.9875.006394
HSA-MIR-60799.9773.625593
HSA-MIR-314899.9775.066478
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-568899.9673.234504
HSA-MIR-495-3P99.9672.814197
HSA-MIR-6755-5P99.9565.59464
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-101-3P99.9475.032230
HSA-MIR-144-3P99.9473.982698
HSA-MIR-452599.9464.38675
HSA-MIR-5010-5P99.9464.11705
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-311999.9271.342390

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriokansl1lENSDARG00000075284
mus_musculusKansl1lENSMUSG00000026004
rattus_norvegicusKansl1lENSRNOG00000028149
drosophila_melanogasternsl1FBGN0262527

Paralogs (1): KANSL1 (ENSG00000120071)

Protein

Protein identifiers

KAT8 regulatory NSL complex subunit 1-like proteinA0AUZ9 (reviewed: A0AUZ9)

Alternative names: MSL1v2

All UniProt accessions (5): A0AUZ9, A0A0U1RR24, H7BZ78, H7C1T2, H7C2S5

UniProt curated annotations — full annotation on UniProt →

Post-translational modifications. Acetylated on lysine residues by KAT8 upon ionizing radiation-induced DNA damage; deacetylated by HDAC3.

Isoforms (4)

UniProt IDNamesCanonical?
A0AUZ9-11yes
A0AUZ9-22
A0AUZ9-33
A0AUZ9-44

RefSeq proteins (2): NP_001294905, NP_689732* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026180NSL1Family
IPR029332PEHE_domDomain

Pfam: PF15275

UniProt features (22 total): sequence conflict 8, splice variant 5, region of interest 2, compositionally biased region 2, modified residue 2, chain 1, domain 1, cross-link 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A0AUZ9-F150.480.07

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (3): 462, 859, 134

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 175 (showing top): CREL_01, TGCGCANK_UNKNOWN, GCANCTGNY_MYOD_Q6, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, SP1_Q2_01, MYCMAX_01, BASAKI_YBX1_TARGETS_DN, ZHANG_BREAST_CANCER_PROGENITORS_UP, BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP, OCT1_B, YNGTTNNNATT_UNKNOWN, GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX, GOCC_TRANSFERASE_COMPLEX, YGCGYRCGC_UNKNOWN, AHR_Q5

GO Biological Process (0):

GO Molecular Function (1): histone acetyltransferase binding (GO:0035035)

GO Cellular Component (3): NSL complex (GO:0044545), histone acetyltransferase complex (GO:0000123), H4 histone acetyltransferase complex (GO:1902562)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
enzyme binding1
H4 histone acetyltransferase complex1
chromatin1
protein acetyltransferase complex1
histone acetyltransferase complex1

Protein interactions and networks

STRING

604 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KANSL1LOR7G2Q8NG99513
KANSL1LLANCL1O43813500
KANSL1LKAT8Q9H7Z6469
KANSL1LEP400Q96L91437
KANSL1LMYL1P05976436
KANSL1LADAM11O75078427
KANSL1LADAM23O75077411
KANSL1LNUP210LQ5VU65409
KANSL1LMB21D2Q8IYB1397
KANSL1LKANSL3Q9P2N6388
KANSL1LZNF736B4DX44380
KANSL1LCSRNP3Q8WYN3379
KANSL1LMYL4P11783369
KANSL1LZNG1EQ5RIA9359
KANSL1LZNG1FQ4V339357
KANSL1LZNG1CQ5JTY5357

IntAct

5 interactions, top by confidence:

ABTypeScore
PHF20L1KANSL1Lpsi-mi:“MI:0914”(association)0.350
MAGEA10KANSL1Lpsi-mi:“MI:0914”(association)0.350
EXOC1KANSL1Lpsi-mi:“MI:0915”(physical association)0.000
KANSL1LOPTNpsi-mi:“MI:0915”(physical association)0.000

BioGRID (6): KANSL1L (Two-hybrid), KANSL1L (Affinity Capture-MS), KANSL1L (Protein-peptide), KANSL1L (Cross-Linking-MS (XL-MS)), BCLAF1 (Cross-Linking-MS (XL-MS)), KANSL1L (Affinity Capture-RNA)

ESM2 similar proteins: A0AUZ9, A0JMF7, A1L2Y1, A3KMW7, A8MT70, A8MW92, A9JRX0, B0CM36, B0S6S9, B7ZS37, D3Z987, F1QB81, O95447, P40649, Q0IHW6, Q0P5X5, Q14B48, Q15468, Q3U285, Q3V089, Q49A88, Q4R815, Q4V9H5, Q5CZC0, Q5DTI6, Q5REF4, Q5T1N1, Q5ZJK5, Q66H35, Q6NRH7, Q6NRK3, Q6ZRS4, Q6ZU52, Q80VP2, Q80WQ8, Q8BLG0, Q8CB14, Q8CCJ9, Q8IUR6, Q8IX21

Diamond homologs: A0AUZ9, Q0IHW6, Q5DTI6, Q80TG1, Q7Z3B3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

156 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance128
Likely benign5
Benign2

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
2427041NC_000002.11:g.(?210636797)(213403254_?)delPathogenic

SpliceAI

3415 predictions. Top by Δscore:

VariantEffectΔscore
2:210023180:C:CCacceptor_gain1.0000
2:210024028:CTTA:Cdonor_loss1.0000
2:210024029:TTAC:Tdonor_loss1.0000
2:210024030:TA:Tdonor_loss1.0000
2:210024031:A:ACdonor_gain1.0000
2:210024031:AC:Adonor_gain1.0000
2:210024031:ACCTT:Adonor_loss1.0000
2:210024032:C:CGdonor_gain1.0000
2:210024032:CC:Cdonor_gain1.0000
2:210024197:AAGCT:Aacceptor_gain1.0000
2:210024198:AGCT:Aacceptor_gain1.0000
2:210024200:CT:Cacceptor_gain1.0000
2:210024201:TC:Tacceptor_loss1.0000
2:210024202:C:CCacceptor_gain1.0000
2:210024215:C:CTacceptor_gain1.0000
2:210024216:A:Tacceptor_gain1.0000
2:210027289:AGCTT:Adonor_loss1.0000
2:210027290:GCTTA:Gdonor_loss1.0000
2:210027291:CTTA:Cdonor_loss1.0000
2:210027292:TTA:Tdonor_loss1.0000
2:210027293:TACC:Tdonor_loss1.0000
2:210027294:A:ACdonor_gain1.0000
2:210027294:ACCTC:Adonor_loss1.0000
2:210027295:C:CCdonor_gain1.0000
2:210027295:C:Gdonor_loss1.0000
2:210027295:CCT:Cdonor_gain1.0000
2:210027351:C:CCacceptor_gain1.0000
2:210028841:ATACC:Adonor_loss1.0000
2:210028842:TAC:Tdonor_loss1.0000
2:210028843:A:ACdonor_gain1.0000

AlphaMissense

6524 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:210098197:A:GL480S0.999
2:210129107:A:GL385P0.998
2:210129117:A:GW382R0.998
2:210129117:A:TW382R0.998
2:210027349:A:GW800R0.997
2:210027349:A:TW800R0.997
2:210129086:A:GL392P0.997
2:210028862:C:AK793N0.996
2:210028862:C:GK793N0.996
2:210104123:A:GL470P0.996
2:210129065:A:GL399P0.996
2:210028911:A:GI777T0.995
2:210104126:A:GL469P0.995
2:210129135:C:GA376P0.995
2:210104137:G:CS465R0.994
2:210104137:G:TS465R0.994
2:210104139:T:GS465R0.994
2:210129102:C:GA387P0.994
2:210028857:A:TI795K0.993
2:210028917:A:CI775S0.993
2:210098205:A:CS477R0.993
2:210098205:A:TS477R0.993
2:210098207:T:GS477R0.993
2:210153871:C:GA238P0.993
2:210027347:C:AW800C0.992
2:210027347:C:GW800C0.992
2:210028857:A:GI795T0.992
2:210028867:A:GY792H0.992
2:210028917:A:TI775N0.992
2:210075628:G:TA560D0.992

dbSNP variants (sampled 300 via entrez): RS1000005896 (2:210085716 T>C), RS1000020421 (2:210026817 C>T), RS1000021835 (2:210172320 G>A), RS1000023764 (2:210034668 G>A), RS1000038238 (2:210167965 T>C), RS1000039442 (2:210130859 T>C), RS1000059840 (2:210085481 T>A), RS1000070758 (2:210168246 T>C,G), RS1000105602 (2:210121762 G>A,T), RS1000118797 (2:210078689 G>A), RS1000153363 (2:210139561 C>A), RS1000169193 (2:210078443 A>C), RS1000171683 (2:210051820 G>A), RS1000182901 (2:210140703 T>C), RS1000209950 (2:210149702 C>T)

Disease associations

OMIM: gene MIM:613833 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST006249_98Serum metabolite levels2.000000e-24
GCST006249_99Serum metabolite levels3.000000e-33
GCST011053_7Neuroblastoma (pediatric)2.000000e-16

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

27 total (human), top 27 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases expression, decreases methylation, affects expression7
bisphenol Aincreases expression, increases methylation2
sodium arseniteaffects expression, increases expression2
aristolochic acid Idecreases expression1
TAK-243increases sumoylation1
methylmercuric chloridedecreases expression1
butyraldehydedecreases expression1
entinostatdecreases expression1
belinostatdecreases expression1
abrineincreases expression1
jinfukangdecreases expression1
Sunitinibincreases expression1
Air Pollutantsdecreases expression, increases abundance1
Arsenicaffects methylation1
Benzo(a)pyrenedecreases methylation1
Coaldecreases expression, increases abundance1
Doxorubicindecreases expression1
Estradioldecreases expression, increases reaction1
Formaldehydedecreases expression1
Progesteroneincreases expression1
Smokedecreases expression, increases abundance1
Thimerosalincreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
Cyclosporinedecreases expression1
Aflatoxin B1decreases methylation1
Antirheumatic Agentsincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): neuroblastoma